Ehlers-Danlos patients reported sustained improvements in pain-specific metrics, as well as improvements in sleep and anxiety following cannabis therapy.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Childhood depression and other psychological factors significantly predict future initiation of tobacco and cannabis, researchers concluded.
Alcohol sales experienced historic declines while retail cannabis sales increased over ten percent, according to data provided by the Canadian government.
While delta-8-THC and delta-9-THC were the most frequently identified synthetically derived cannabinoids, investigators also identified highly potent novel cannabinoids such as THCP and HHC in nearly one-third to one-half of products.
Respondents were most likely to report using cannabis to manage pain or mobility (81 percent), sleep (62 percent), PTSD or anxiety (43 percent), stress (43 percent), and depression (29 percent).
If enacted next year, no future initiatives pertaining to how marijuana or other controlled substances are regulated will be permitted to appear on the Idaho ballot.
Under current law, state-registered patients may possess either herbal cannabis or infused tinctures, capsules, or topical patches.
“Our findings add to the growing evidence supporting the potential benefits of cannabis use among people who use drugs,” researcher concluded.